{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:37:15Z","timestamp":1763037435687,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jacl.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T11:17:08Z","timestamp":1586776628000},"page":"293-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Progressively decreasing plasma high-density lipoprotein cholesterol levels preceding diagnosis of smoldering myeloma"],"prefix":"10.1016","volume":"14","author":[{"given":"Hagai","family":"Tavori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle J.","family":"Ormseth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica S.","family":"Lilley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney R.","family":"Papen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"May-Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean S.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MacRae F.","family":"Linton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2020.04.001_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jacl.2007.02.003","article-title":"Severe acquired (secondary) high-density lipoprotein deficiency","volume":"1","author":"Goldberg","year":"2007","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2020.04.001_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00392-010-0186-y","article-title":"Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia","volume":"99","author":"van Gorselen","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacl.2020.04.001_bib3","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1161\/01.ATV.0000032153.19645.5C","article-title":"Acquired HDL deficiency associated with apolipoprotein A-I reactive monoclonal immunoglobulins","volume":"22","author":"Mendez","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2020.04.001_bib4","doi-asserted-by":"crossref","first-page":"19022","DOI":"10.1074\/jbc.RA119.009424","article-title":"Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia","volume":"294","author":"May-Zhang","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2020.04.001_bib5","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/art.21288","article-title":"Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors","volume":"52","author":"Chung","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacl.2020.04.001_bib6","doi-asserted-by":"crossref","first-page":"18473","DOI":"10.1074\/jbc.M110.118182","article-title":"Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway","volume":"285","author":"Shao","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2020.04.001_bib7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1194\/jlr.M800607-JLR200","article-title":"HDL is the major lipoprotein carrier of plasma F2-isoprostanes","volume":"50","author":"Proudfoot","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2020.04.001_bib8","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1074\/jbc.RA117.001099","article-title":"Modification by isolevuglandins, highly reactive gamma-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function","volume":"293","author":"May-Zhang","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2020.04.001_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1373\/clinchem.2003.027813","article-title":"Artifactual undetectable HDL-cholesterol with the Beckman synchron LX and vitros 950 assays temporally associated with a paraprotein","volume":"50","author":"Baca","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2020.04.001_bib10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/clinchem\/48.6.964","article-title":"Monoclonal paraprotein may interfere with the Roche direct HDL-C Plus assay","volume":"48","author":"Kadri","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2020.04.001_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1388-1981(00)00038-X","article-title":"Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway","volume":"1485","author":"Salomon","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacl.2020.04.001_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00277-007-0375-6","article-title":"Cholesterol levels in patients with multiple myeloma","volume":"87","author":"Yavasoglu","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jacl.2020.04.001_bib13","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1056\/NEJMcpc069031","article-title":"Case records of the Massachusetts General Hospital. Case 40-2006. A 64-year-old man with anemia and\u00a0a low level of HDL cholesterol","volume":"355","author":"Murali","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287420300714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287420300714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:34:53Z","timestamp":1761831293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287420300714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1933287420300714"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2020.04.001","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressively decreasing plasma high-density lipoprotein cholesterol levels preceding diagnosis of smoldering myeloma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}